1. Home
  2. NVX vs ATYR Comparison

NVX vs ATYR Comparison

Compare NVX & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NOVONIX Limited American Depository Shares

NVX

NOVONIX Limited American Depository Shares

HOLD

Current Price

$0.72

Market Cap

144.3M

Sector

Miscellaneous

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.77

Market Cap

73.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVX
ATYR
Founded
2012
2005
Country
Australia
United States
Employees
192
58
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
144.3M
73.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NVX
ATYR
Price
$0.72
$0.77
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
$3.67
AVG Volume (30 Days)
378.9K
933.9K
Earning Date
04-23-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3,904.19
N/A
Revenue Next Year
$91.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.61
$0.64
52 Week High
$3.86
$7.29

Technical Indicators

Market Signals
Indicator
NVX
ATYR
Relative Strength Index (RSI) 44.21 42.45
Support Level $0.63 $0.68
Resistance Level $0.81 $0.85
Average True Range (ATR) 0.05 0.05
MACD 0.01 0.00
Stochastic Oscillator 44.24 35.93

Price Performance

Historical Comparison
NVX
ATYR

About NVX NOVONIX Limited American Depository Shares

NOVONIX Ltd is a battery technology company developing and scaling materials and equipment critical to the lithium-ion battery supply chain. The company has three operating segments: Battery Materials: It develops and manufactures battery anode materials, ii) Battery Technology: It develops and manufactures battery cell testing equipment, performs consulting services and carries out research and development in battery development, and Graphite Exploration: It manages the maintenance and future development of Mount Dromedary natural graphite deposit. The majority of the company's revenue is derived from the Battery Technology segment. Geographically, the maximum revenue is derived from North America, followed by Asia, and Europe.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: